Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
BMT CTN 1302- Multicenter Phase II, Double Blinded, Placebo Controlled Trial of Maintenance Ixazomib after Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Multiple Myeloma
Grant
Overview
Affiliation
Overview
Awarded By
National Marrow Donor Program
Total Award Amount
28636.00
Direct Costs
19284.00
Sponsor Award Id
10022
Affiliation
Contributor
Racquel Innis-Shelton M.D.
Principal Investigator